The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
PI3Kδ抑制剂zandelisib间歇给药治疗复发/难治性滤泡性淋巴瘤：一项全球II期研究的结果
期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.138
Zelenetz, Andrew D; Jurczak, Wojciech; Ribrag, Vincent; Linton, Kim; Collins, Graham P; Jiménez, Javier L; Bishton, Mark; Dholaria, Bhagirathbhai; Mengarelli, Andrea; Phillips, Tycel J; Sungala, Nagendraprasad; Musuraca, Gerardo; Sheehy, Oonagh; Van Den Neste, Eric; Odera, Mitsuhiko; Miao, Lu; Gold, Daniel P; Ghalie, Richard G; Zinzani, Pier L
